Cyient DLM Ltd. share price target

We have changed our FY26E/FY27E EPS by -1.2%/+2.4% led by weakness in global demand in the short-term. Hence, we have reduced P/E multiple
to 30x (34x earlier). We value Cyient DLM at 30x P/E on FY27E EPS, implying a target price of INR 661.0 per share and reiterate our “BUY” rating on the stock.

Cyient DLM’s (CYIENTDL) 4QFY25 consolidated revenue/EBITDA grew ~18%/51% YoY. EBITDA margins surpassed our estimates, expanding 290bp YoY, led by a favorable product mix, operational efficiencies, and one-offs (~250bp).

Cyient DLM reported a 38%/14% year-over-year (YoY) revenue growth during Q3FY25, driven by INR 870 million in revenue from the recently acquired Altek. However, on a standalone basis, revenue grew by only 11%. Net profits were significantly impacted due to acquisition-related costs.

Cyient DLM’s (CYIENTDL) 3QFY25 consolidated revenue/EBITDA grew by ~38%/23% YoY. However, EBITDA missed our estimates as margins declined 90bp YoY due to a high mix of low-margin business (BEL order execution)

Navigating the evolution of EMS in India

Cyient DLM (CYIENTDL) reported a strong quarter, with revenue growth of ~33% YoY in 2QFY25, led by significant traction in the defense (up 82% YoY) and aerospace (up 20% YoY) verticals.

Firming the Feet in Critical Services: Cyient DLM is firming its feet as integrated Electronic Manufacturing Services (EMS) provider, with a strong focus on critical solutions across the defense, aerospace, industrial, medical, and transportation sectors. The recent acquisition
of Altek Electronics highlights Cyient's strategic intent to create synergies in the U.S. market, particularly in the industrial, medical and defense sector, supported by Altek’s ITAR certification.

Cyient DLM (CYIENTDL) reported a healthy quarter, with revenue growth of ~19% YoY in 1QFY25, led by significant traction in the aerospace and defense verticals.

Cyient DLM (CYIENTDL) reported another quarter of strong revenue
growth. Its revenue jumped ~30% YoY in 4QFY24, fueled by significant
traction from the Defense (+78% YoY) and Aerospace (+52% YoY) verticals.
However, EBITDA margin contracted 100bp YoY to 10.5%, primarily due to
the increase in SG&A expenses

IPO NOTE